Author

Dipti Sadalge

Foghorn Therapeutics (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1 Assay:protein structure· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Alexis Khalil· 1 shared Asad M. TaherbhoyiD· 1 shared Bengi Turegun· 1 shared David C.S. HuangiD· 1 shared David L. Lahr· 1 shared Derek M. Musser· 1 shared Gabriel J. Sandoval· 1 shared Gavin M. Palowitch· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Alexis Khalil

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Structural and functional basis of PU.1-BAF interaction enables targeting of lineage-specific transcription

Dipti Sadalge, Jozlyn R. Clasman, Salih Topal, Derek M. Musser, Laura Von der Porten, Siying Wu, Samantha E. Schultz, Wesley Austin, David C.S. Huang, Ying‐Duo Gao, Jeremy W. Setser, Marissa R. Martinez, Janna Kiselar, Stephen Hesler, Sydney J. Blevins, , Asad M. Taherbhoy

This paper identifies the structural basis of PU.1-BAF interaction and shows small molecules can disrupt it, offering a new therapeutic strategy for cancer.

bioRxiv · Aug 1, 2025 · PreprintMolecular Biology